A Study of ST-01156 in People With Solid Tumor Cancer

Full Title

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients with Advanced Solid Malignancies

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Robert Maki’s office at 646-888-5059.

Protocol

26-002

Phase

Phase I (phase 1)

Investigator

Robert Maki

Co-Investigators

Mrinal M. Gounder

Diseases

Endometrial and other Uterine Cancers › Endometrial Cancer
Primary Bone › Ewing Sarcoma
Sarcomas › Ewing Sarcoma
Solid Tumors

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT07197554

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description